Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90–Cdc37, a Kinome Chaperone–Cochaperone, by Triterpene Celastrol
- 22 July 2009
- journal article
- research article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 48 (32), 5853-5855
- https://doi.org/10.1002/anie.200900929
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitorsOncogene, 2008
- Targeting the oncogene and kinome chaperone CDC37Nature Reviews Cancer, 2008
- A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cellsMolecular Cancer Therapeutics, 2008
- Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsCancer Cell, 2006
- Celastrol, a Triterpene Extracted from the Chinese “Thunder of God Vine,” Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude MiceCancer Research, 2006
- Monitoring the Effects of Antagonists on Protein−Protein Interactions with NMR SpectroscopyJournal of the American Chemical Society, 2005
- Hsp90 and Cdc37 – a chaperone cancer conspiracyCurrent Opinion in Genetics & Development, 2005
- Theory and Applications of NMR-Based Screening in Pharmaceutical ResearchChemical Reviews, 2004
- The Cdc37 protein kinase–binding domain is sufficient for protein kinase activity and cell viabilityThe Journal of cell biology, 2002
- NMR screening techniques in drug discovery and drug designProgress in Nuclear Magnetic Resonance Spectroscopy, 2002